Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, KOZARICH JOHN W, holds the title of Director at LIGAND PHARMACEUTICALS INC.
On 2026-05-13, the insider transacted 4,535 shares.The shares were transacted at a weighted average price of $155.34 per share, resulting in a total market-relevant value of $704K.
KOZARICH JOHN W (Director) sold $704K of $LGND
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.